Business Context and Reporting Period
This Form 8-K was filed by WellPoint, Inc. (now Elevance Health, Inc.) on September 22, 2006. The report details the completion of a secondary public offering of common stock by a selling stockholder, The New York Public Asset Fund, rather than a primary offering by the company.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity for the reporting period. The only financial data disclosed relates to the specific transaction:
- Shares Sold: 7,000,000 shares of common stock.
- Price to Underwriters: $74.9522 per share.
- Public Offering Price: $77.50 per share.
- Company Proceeds: $0 (The Company did not receive any proceeds from the sale).
Material Changes
The material change reported is the entry into and completion of an underwriting agreement on September 18 and September 22, 2006, respectively. This transaction resulted in a change of ownership for 7,000,000 shares from The New York Public Asset Fund to the public market. There is no indication of changes to the company's operational structure or capitalization from this specific filing.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies beyond the standard disclosure that the Underwriting Agreement is incorporated by reference. The document focuses solely on the mechanics of the stock sale.
Investor Verification Checklist
- Verify the impact of the 7,000,000 share sale on total outstanding shares and potential dilution.
- Confirm the identity and remaining holdings of The New York Public Asset Fund post-transaction.
- Review the full Underwriting Agreement (Exhibit 1.1) for any lock-up provisions or indemnity clauses.
- Note that the company received no capital from this transaction; verify if this was part of a larger capital strategy.